CAT# | CPM-1-0438 |
Sequence | RMPEAAPPV |
Size | 50 Test, 100 Test | Antigen | Cancer | Epitope Origin | p53 | MHC Restriction | HLA-A_02_01 | Conjugate | BV421 |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0587 | HLA-A_02_01 Her-2/neu E75 tetramer-KIFGSLAFL-PE labeled | Inquiry | ||
CPM-1-0334 | H-2Db Survivin tetramer-ATFKNWPFL-BV421 labeled | Inquiry | ||
CPM-1-0398 | HLA-B_07_02 HPV E7 tetramer-KPTLKEYVL-PE labeled | Inquiry | ||
CPM-1-0114 | HLA-A_02_01 MAGE-A3 112-120 tetramer-KVAELVHFL-PE labeled | Inquiry | ||
CPM-1-0703 | HLA-B_07_02 DKK1 P68 tetramer-YPGGNKVQT-PE labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Gap 19 is a nonapeptide derived from the cytoplasmic loop (CL) of Connexin-43 (Cx43). Cx43 is a predominant card ...
Orexin A (OXA) and orexin B (OXB) are hypothalamic neuropeptides discovered in 1998, which bind to two G-protein ...
Catestain, a 21 amino acid fragment of chromogranin A (CgA), is divided into human CgA352-372 and bovine CgA344- ...
of skin aging Skin aging is an obvious external manifestation of the natural process occurring in tissues and or ...
Obestatin is a 23-amino acid peptide hormone produced in specific epithelial cells of the stomach and small inte ...